Daniel Simhaee
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,686 | 4 | 56.0% |
| Food and Beverage | $1,227 | 20 | 40.7% |
| Education | $99.99 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $1,686 | 4 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $255.65 | 2 | $0 (2024) |
| Alcon Vision LLC | $231.56 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $181.21 | 6 | $0 (2024) |
| Amgen Inc. | $125.00 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $118.46 | 1 | $0 (2018) |
| Spark Therapeutics, Inc. | $101.85 | 1 | $0 (2018) |
| Eyevance Pharmaceuticals LLC | $94.97 | 1 | $0 (2021) |
| ABBVIE INC. | $84.16 | 3 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $69.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.95 | 10 | Regeneron Healthcare Solutions, Inc. ($130.65) |
| 2023 | $295.61 | 6 | Mallinckrodt Hospital Products Inc. ($146.75) |
| 2021 | $94.97 | 1 | Eyevance Pharmaceuticals LLC ($94.97) |
| 2019 | $1,221 | 4 | Regeneron Pharmaceuticals, Inc. ($998.65) |
| 2018 | $908.04 | 4 | Regeneron Pharmaceuticals, Inc. ($687.73) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: EYE CARE | ||||||
| 11/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: EYE CARE | ||||||
| 08/28/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $130.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: EYE CARE | ||||||
| 12/22/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: DRY EYE | ||||||
| 07/19/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/13/2021 | Eyevance Pharmaceuticals LLC | Tobradex ST (Drug) | Food and Beverage | In-kind items and services | $94.97 | General |
| Category: Anti-Infective/Steroid | ||||||
| 06/15/2019 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $152.86 | General |
| Category: Ophthalmology | ||||||
| 05/31/2019 | Carl Zeiss Meditec, Inc. | — | Food and Beverage | In-kind items and services | $69.76 | General |
| 04/12/2019 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $500.00 | General |
| 04/12/2019 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $498.65 | General |
| 10/27/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $118.46 | General |
| 10/18/2018 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $101.85 | General |
| Category: OCULAR | ||||||
| 04/14/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $400.00 | General |
| 04/14/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $287.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 287 | 565 | $113,159 | $33,911 |
| 2022 | 7 | 326 | 715 | $155,552 | $47,411 |
| 2021 | 8 | 327 | 790 | $167,103 | $52,482 |
| 2020 | 6 | 168 | 340 | $73,117 | $23,543 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 22 | 72 | $26,772 | $7,875 | 29.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 41 | 68 | $23,221 | $6,778 | 29.2% |
| 92134 | Imaging of retina | Office | 2023 | 72 | 173 | $19,137 | $5,848 | 30.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 50 | 77 | $19,616 | $5,789 | 29.5% |
| 92250 | Photography of the retina | Office | 2023 | 60 | 103 | $10,980 | $3,234 | 29.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 15 | 44 | $7,832 | $2,417 | 30.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 13 | 13 | $5,046 | $1,762 | 34.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 14 | 15 | $555.00 | $208.71 | 37.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 57 | 127 | $47,191 | $13,983 | 29.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 23 | 89 | $32,739 | $10,393 | 31.7% |
| 92134 | Imaging of retina | Office | 2022 | 87 | 201 | $24,231 | $6,972 | 28.8% |
| 92250 | Photography of the retina | Office | 2022 | 72 | 161 | $17,163 | $5,691 | 33.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 53 | 70 | $18,550 | $5,448 | 29.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 18 | 51 | $8,657 | $2,784 | 32.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 16 | 16 | $7,022 | $2,139 | 30.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 77 | 176 | $65,373 | $20,429 | 31.2% |
| 67028 | Injection of drug into eye | Office | 2021 | 24 | 93 | $32,187 | $10,242 | 31.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 84 | 239 | $28,777 | $8,905 | 30.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 38 | 59 | $15,615 | $4,813 | 30.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 17 | 49 | $8,318 | $2,747 | 33.0% |
| 92250 | Photography of the retina | Office | 2021 | 41 | 60 | $6,949 | $2,307 | 33.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 12 | 12 | $5,236 | $1,593 | 30.4% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 34 | 102 | $4,648 | $1,446 | 31.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 51 | 105 | $37,674 | $12,333 | 32.7% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 56 | 127 | $15,142 | $4,746 | 31.3% |
About Daniel Simhaee
Daniel Simhaee is a Student in an Organized Health Care Education/Training Program healthcare provider based in Elmhurst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1043654973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Simhaee has received a total of $3,014 in payments from pharmaceutical and medical device companies, with $493.95 received in 2024. These payments were reported across 25 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($1,686).
As a Medicare-enrolled provider, Simhaee has provided services to 1,108 Medicare beneficiaries, totaling 2,410 services with total Medicare billing of $157,347. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Ophthalmology
- Location Elmhurst, NY
- Active Since 04/22/2013
- Last Updated 03/02/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1043654973
Products in Payments
- ACTHAR (Biological) $181.21
- Constellation (Device) $152.86
- EYLEA HD (Biological) $130.65
- EYLEA (Biological) $125.00
- TEPEZZA (Biological) $125.00
- LUXTURNA (Biological) $101.85
- Tobradex ST (Drug) $94.97
- OZURDEX (Drug) $84.16
- Clareon (Device) $78.70
- TYRVAYA (Drug) $23.86
- YUTIQ (Drug) $20.73
- Izervay (Drug) $20.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Elmhurst
Marina Matatova, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $6,031
Adelina Hung, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,754
Dr. Jason Bastida, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $1,933
Shiraz Azim, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,652
Dr. Catalina Nino, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,566
Bhanu Singh
Student in an Organized Health Care Education/Training Program — Payments: $1,031